Respondents outlined the existence of weaknesses within current national DS-TB health services including the provision of expired drugs, lack of drug availability and drug stock outs, lack of staff availability for refill dispensing, and lack of support and information to encourage patients to adhere to treatment. There is need for adequate treatment provision for DS-TB in order to prevent the selection of naturally occurring mutations that cause MDR-TB to develop [27]. Our results highlighted the importance of a strengthened drug supply line to villages, since the role of supply interruptions for TB medication in development of MDR resistance was acknowledged by both patients and medical staff. The negative effects of drug stock outs have been shown in HIV, though there is a dearth of research in this area for TB [28]. To address the issue of interrupted drug supply lines, MSF has trained suppliers and relevant Ministry of Health staff in medical supply ordering processes.